Medicine & Life Sciences
Alzheimer Disease
100%
Cognitive Dysfunction
74%
Dementia
62%
Amyloid
59%
Frontotemporal Dementia
36%
Frontotemporal Lobar Degeneration
30%
Brain
28%
Atrophy
27%
Biomarkers
26%
Cognition
26%
White Matter
22%
Atherosclerosis
22%
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
22%
Positron-Emission Tomography
20%
Pathology
18%
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
18%
Neuroimaging
16%
Population
13%
Elderly
11%
Temporal Lobe
11%
Magnetic Resonance Imaging
11%
Memory
11%
Apolipoprotein E4
10%
Mutation
9%
Mental Status and Dementia Tests
9%
Gray Matter
9%
Confidence Intervals
8%
Progranulins
8%
Clinical Trials
7%
Primary Progressive Aphasia
7%
Cerebrovascular Disorders
7%
Genome-Wide Association Study
7%
Progressive Supranuclear Palsy
7%
Chromosomes, Human, Pair 9
7%
Cerebrospinal Fluid
7%
DNA-Binding Proteins
7%
Apolipoproteins E
6%
Longitudinal Studies
6%
Odds Ratio
6%
Cohort Studies
6%
Autopsy
6%
Cognitive Aging
6%
National Institute on Aging (U.S.)
6%
Genotype
6%
vascular factor
6%
Depression
6%
Neurofibrillary Tangles
5%
Tauopathies
5%
Aphasia
5%